Because MTG16 expression was upregulated in IBD, we wondered whether MTG16 expression would be increased in IBD-driven colon cancer (CAC) compared with sporadic colorectal cancer (CRC). The gene discussed is CBFA2T3; the disease is malignant colon neoplasm.